Amphastar Pharmaceuticals, Inc. (AMPH)

23.20 -0.64 (-2.68%) USD  |  NASDAQ  |  Sep 04, 16:00
22.90 -0.30 (-1.29%) After-Hours: 20:00
More

Amphastar Pharmaceuticals Cash and Short Term Investments (Annual) : 285.25M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for AMPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2011. Start Trial.
Date Value
December 31, 2025 285.25M
December 31, 2024 224.08M
December 31, 2023 259.24M
December 31, 2022 178.20M
December 31, 2021 139.11M
December 31, 2020 109.68M
December 31, 2019 89.52M
December 31, 2018 93.32M
Date Value
December 31, 2017 72.38M
December 31, 2016 74.27M
December 31, 2015 67.36M
December 31, 2014 69.32M
December 31, 2013 54.91M
December 31, 2012 52.10M
December 31, 2011 0.00

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Viatris, Inc. 1.454B
Supernus Pharmaceuticals, Inc. 308.67M
Liquidia Corp. 190.68M
ANI Pharmaceuticals, Inc. 294.75M
Corcept Therapeutics, Inc. 372.15M